Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02TLZ
|
|||
| Former ID |
DNC011681
|
|||
| Drug Name |
3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide
|
|||
| Synonyms |
CHEMBL178053; 3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide; ZINC28103871; BDBM50015167; (E)-3-[4-Phenylphenyl]-N-methyl-2-propenehydroxamic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H15NO2
|
|||
| Canonical SMILES |
CN(C(=O)C=CC1=CC=C(C=C1)C2=CC=CC=C2)O
|
|||
| InChI |
1S/C16H15NO2/c1-17(19)16(18)12-9-13-7-10-15(11-8-13)14-5-3-2-4-6-14/h2-12,19H,1H3/b12-9+
|
|||
| InChIKey |
TUEHLNCQVBWQNV-FMIVXFBMSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.